4.7 Article

Inhibition of Cdc42 activity extends lifespan and decreases circulating inflammatory cytokines in aged female C57BL/6 mice

Journal

AGING CELL
Volume 19, Issue 9, Pages -

Publisher

WILEY
DOI: 10.1111/acel.13208

Keywords

aging; Cdc42; epigenetic clock; inflammaging; interferon gamma; lifespan

Funding

  1. Deutsche Forschungsgemeinschaft [FOR2674, RTG1789, SFB1074, SFB1279, WW1706/8-1, WW1706/12-1]

Ask authors/readers for more resources

Cdc42 is a small RhoGTPase regulating multiple functions in eukaryotic cells. The activity of Cdc42 is significantly elevated in several tissues of aged mice, while the Cdc42 gain-of-activity mouse model presents with a premature aging-like phenotype and with decreased lifespan. These data suggest a causal connection between elevated activity of Cdc42, aging, and reduced lifespan. Here, we demonstrate that systemic treatment of aged (75-week-old) female C57BL/6 mice with a Cdc42 activity-specific inhibitor (CASIN) for 4 consecutive days significantly extends average and maximum lifespan. Moreover, aged CASIN-treated animals displayed a youthful level of the aging-associated cytokines IL-1 beta, IL-1 alpha, and INF gamma in serum and a significantly younger epigenetic clock as based on DNA methylation levels in blood cells. Overall, our data show that systemic administration of CASIN to reduce Cdc42 activity in aged mice extends murine lifespan.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Investigation of measurable residual disease in acute myeloid leukemia by DNA methylation patterns

Tanja Bozic, Chao-Chung Kuo, Jan Hapala, Julia Franzen, Monika Eipel, Uwe Platzbecker, Martin Kirschner, Fabian Beier, Edgar Jost, Christian Thiede, Wolfgang Wagner

Summary: The study proposed an alternative method to estimate MRD based on AML-associated DNA methylation patterns, which could reliably distinguish malignant and healthy samples by identifying abnormal DNAm patterns. However, since healthy samples may also contain abnormal-classified DNAm reads, the approach does not yet reliably differentiate between MRD positive and negative samples.

LEUKEMIA (2022)

Article Medical Laboratory Technology

Toward Clinical Application of Leukocyte Counts Based on Targeted DNA Methylation Analysis

Stephanie Sontag, Ledio Bocova, Wouter H. G. Hubens, Selina Nuechtern, Matthis Schnitker, Thomas Look, Kema M. Schroeder, Birgit Pluemaekers, Vithurithra Tharmapalan, Martina Wessiepe, Thomas Kraus, Jan Kramer, Lothar Rink, Steffen Koschmieder, Wolfgang Wagner

Summary: The study further optimized and validated targeted DNAm assays for leukocyte deconvolution using blood samples from healthy donors, ring trial participants, and patients with hematological diseases. Results showed that relative leukocyte quantification correlated with conventional blood counts using pyrosequencing or ddPCR, but outliers in epigenetic leukocyte counts were observed in some patients, especially those with hematopoietic malignancies. Further optimization of assays is needed for accurate absolute quantification.

CLINICAL CHEMISTRY (2022)

Article Medicine, Legal

Evidence for differences in DNA methylation between Germans and Japanese

J. Becker, P. Boehme, A. Reckert, S. B. Eickhoff, B. E. Koop, J. Blum, T. Guenduez, M. Takayama, W. Wagner, S. Ritz-Timme

Summary: The study directly compared age-associated DNA methylation patterns in German and Japanese donors, finding significant differences in certain CpG sites. However, the age prediction models based on multiple robust CpG sites did not reveal relevant differences between the two populations, suggesting the need for further research to ensure high quality age estimation.

INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2022)

Article Oncology

Physical activity specifically evokes release of cell-free DNA from granulocytes thereby affecting liquid biopsy

Elmo W. I. Neuberger, Stephanie Sontag, Alexandra Brahmer, Keito F. A. Philippi, Markus P. Radsak, Wolfgang Wagner, Perikles Simon

Summary: Physical activity leads to an increase in cell-free DNA, with the majority of this DNA originating from granulocytes, which could compromise the accuracy of liquid biopsy.

CLINICAL EPIGENETICS (2022)

Article Engineering, Biomedical

The spatial self-organization within pluripotent stem cell colonies is continued in detaching aggregates

Roman Goetzke, Giulio Abagnale, Burcu Yesilyurt, Lucia Salz, Olivia Cypris, Philipp Glueck, Sven Liesenfelder, Kira Zeevaert, Zhiyao Ma, Ronghui Li, Ivan G. Costa, Angelika Lampert, Vivek Pachauri, Uwe Schnakenberg, Martin Zenke, Wolfgang Wagner, Mohamed H. Elsafi Mabrouk, Marcelo A. S. Toledo

Summary: Colonies of induced pluripotent stem cells (iPSCs) exhibit self-organization and transition into 3D aggregates. This transition is characterized by gradual upregulation of specific genes and the formation of embryoid bodies (EBs). The use of polydimethylsiloxane (PDMS) pillars or micro-contact printing of vitronectin plays a role in spatial confinement and the formation of controlled size EBs without enzymatic or mechanical treatment.

BIOMATERIALS (2022)

Article Medicine, Legal

Altered DNA methylation at age-associated CpG sites in children with growth disorders: impact on age estimation?

F. Mayer, J. Becker, C. Reinauer, P. Boehme, S. B. Eickhoff, B. Koop, T. Guenduez, J. Blum, W. Wagner, S. Ritz-Timme

Summary: This study investigates the application of age estimation based on DNA methylation in healthy children and children with growth disorders. The findings suggest that growth disorders can impact epigenetic age predictions and CpGs in genes involved in growth and development should be avoided in age prediction models for children.

INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2022)

Article Cell & Tissue Engineering

Epigenetic biomarkers to track differentiation of pluripotent stem cells

Marco Schmidt, Kira Zeevaert, Mohamed H. Elsafi Mabrouk, Roman Goetzke, Wolfgang Wagner

Summary: Quality control of induced pluripotent stem cells is challenging, and determining trilineage differentiation potential is crucial for validating their pluripotent state. In this study, GermLayerTracker, a combination of site-specific DNA methylation assays, was developed as a biomarker for early germ layer specification. Specific CG dinucleotides (CpGs) with characteristic DNA methylation patterns were identified in the pluripotent state and during differentiation into endoderm, mesoderm, and ectoderm. The GermLayerTracker can be used for quality control of pluripotent cells and to estimate lineage-specific commitment during initial differentiation events.

STEM CELL REPORTS (2023)

Review Biochemistry & Molecular Biology

Epigenetic rejuvenation by partial reprogramming

Deepika Puri, Wolfgang Wagner

Summary: Reprogramming towards pluripotency can rejuvenate cells, reversing age-associated molecular features and evading replicative senescence. However, complete reprogramming can lead to loss of cellular identity and risk of teratoma formation. Limited exposure to reprogramming factors can partially reset epigenetic ageing clocks while maintaining cellular identity. The relationship between rejuvenation and pluripotency, as well as alternative rejuvenation approaches, are discussed in this review.

BIOESSAYS (2023)

Article Engineering, Biomedical

Transformative Materials to Create 3D Functional Human Tissue Models In Vitro in a Reproducible Manner

Jose L. Gerardo-Nava, Jitske Jansen, Daniel Guenther, Laura Klasen, Anja Lena Thiebes, Bastian Niessing, Cedric Bergerbit, Anna A. Meyer, John Linkhorst, Mareike Barth, Payam Akhyari, Julia Stingl, Saskia Nagel, Thomas Stiehl, Angelika Lampert, Rudolf Leube, Matthias Wessling, Francesca Santoro, Sven Ingebrandt, Stefan Jockenhoevel, Andreas Herrmann, Horst Fischer, Wolfgang Wagner, Robert H. Schmitt, Fabian Kiessling, Rafael Kramann, Laura De Laporte

Summary: Recreating human tissues and organs in the petri dish to establish models as tools in biomedical sciences has gained momentum. Transformative materials play an important role in this evolution, as they can be programmed to direct cell behavior and fate. This paper illustrates state-of-the-art developments in in vitro tissue engineering and the challenges related to the design, production, and translation of transformative materials, emphasizing the need for convergence of different technologies to generate functional human tissue models.

ADVANCED HEALTHCARE MATERIALS (2023)

Article Engineering, Biomedical

Transformative Materials for Interfacial Drug Delivery

Prachi Desai, Anshuman Dasgupta, Alexandros Marios Sofias, Quim Pena, Robert Goestl, Ioana Slabu, Ulrich Schwaneberg, Thomas Stiehl, Wolfgang Wagner, Stefan Jockenhoevel, Julia Stingl, Rafael Kramann, Christian Trautwein, Tim H. Bruemmendorf, Fabian Kiessling, Andreas Herrmann, Twan Lammers

Summary: Drug delivery systems (DDS) control drug availability and activity to achieve a balance between therapeutic efficacy and side effects. They overcome biological barriers encountered by drug molecules and are explored for modulating host-material interfaces. This article provides an overview of barriers and interfaces encountered by DDS in different administration routes and highlights material engineering advances for improved disease treatment.

ADVANCED HEALTHCARE MATERIALS (2023)

Article Oncology

Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome

Lucia Salz, Alexander Seitz, Daniel Schaefer, Julia Franzen, Tatjana Holzer, Carlos A. Garcia-Prieto, Iris Buerger, Olaf Hardt, Manel Esteller, Wolfgang Wagner

Summary: CAR T cell expansion during culture leads to DNA hypermethylation, which downregulates the expression of genes relevant to T cell function. This hypermethylation signature can predict cell culture time and is associated with reduced long-term survival and therapeutic outcome in CAR T cell products.

LEUKEMIA (2023)

Article Oncology

Quantification of hematopoietic stem and progenitor cells by targeted DNA methylation analysis

Ledio Bocova, Wouter Hubens, Cordula Engel, Steffen Koschmieder, Edgar Jost, Wolfgang Wagner

Summary: In this study, researchers demonstrate that hematopoietic stem and progenitor cells (HSPCs) can be estimated by targeted DNA methylation (DNAm) analysis. DNAm levels at specific CpG sites in the genes MYO1D, STK17A, and SP140 were found to correlate with CD34(+) cell numbers in mobilized peripheral blood and blast counts in leukemia. These epigenetic biomarkers could potentially be used to assess stem cell mobilization, HSPC harvesting, or blast count in leukemia.

CLINICAL EPIGENETICS (2023)

Article Pharmacology & Pharmacy

Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients

Henrike Jacobi, Margherita Vieri, Marlena Buetow, Carolina Y. Namasu, Laura Flueter, Ivan G. Costa, Tiago Maie, Katharina Lindemann-Docter, Nicolas Chatain, Fabian Beier, Michael Huber, Wolfgang Wagner, Martina Crysandt, Tim H. Bruemmendorf, Mirle Schemionek

Summary: The management of chronic myeloid leukemia (CML) has been revolutionized by tyrosine kinase inhibitors (TKIs), which can induce deep molecular responses and lead to treatment-free remission (TFR) in some patients. However, leukemic stem cells (LSCs) often persist and can cause relapse in patients attempting TKI discontinuation. This study shows that the presence of myelofibrosis (MF) at diagnosis is associated with TFR failure.

FRONTIERS IN PHARMACOLOGY (2023)

Article Oncology

Targeted parallel DNA sequencing detects circulating tumor-associated variants of the mitochondrial and nuclear genomes in patients with neuroblastoma

Lara Rieh, Medhanie Mulaw, Katharina Kneer, Meinhard Beer, Ambros Beer, Thomas F. Bart, Vladimir Benes, Johannes Schulte, Matthias Fischer, Klaus-Michael Debatin, Christian Beltinger

Summary: In this study, tumor-associated mt and nuclear circulating variants were detected in a minority of NB patients, but the number and allelic frequency of the circulating variants did not reflect the clinical course of the tumors.

CANCER REPORTS (2023)

Article Biotechnology & Applied Microbiology

Cell Cluster Sorting in Automated Differentiation of Patient-specific Induced Pluripotent Stem Cells Towards Blood Cells

Zhiyao Ma, Marcelo Augusto Szymanskide Toledo, Paul Wanek, Mohamed H. Elsafi Mabrouk, Francis Smet, Rock Pulak, Simon Pieske, Tobias Piotrowski, Werner Herfs, Christian Brecher, Robert H. Schmitt, Wolfgang Wagner, Martin Zenke

Summary: This article presents an automated platform for efficient and robust cultivation and differentiation of iPS cells into blood cells. By implementing cell cluster sorting and controlling the size of embryoid bodies (EBs), efficient differentiation of iPS cells can be achieved.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)

No Data Available